Search Results - "Bringas, Giosmany"
-
1
Increased C-reactive protein in acute ischemic stroke patients is age dependent
Published in Revista cubana de investigaciones biomédicas (01-07-2020)“…Introduction: Several studies investigating blood biomarkers such as C-reactive protein (CRP) in the prognosis and mortality of stroke have not been…”
Get full text
Journal Article -
2
Clinical trial of neuroEPO in mild‐to‐moderate Alzheimer’s disease
Published in Alzheimer's & dementia (01-12-2021)“…Background NeuroEPO, a nasal pharmaceutical solution of recombinant human erythropoietin with low sialic acid, was in clinical development for the treatment of…”
Get full text
Journal Article -
3
NeuroEPO in mild‐to‐moderate Alzheimer’s disease: Human/Human trials: Cognitive enhancement
Published in Alzheimer's & dementia (01-12-2020)Get full text
Journal Article -
4
NeuroEPO in mild‐to‐moderate Alzheimer’s disease
Published in Alzheimer's & dementia (01-12-2020)“…Background NeuroEPO, is a nasal pharmaceutical solution of recombinant human erythropoietin with low sialic acid. Methods Phase II/III, prospective,…”
Get full text
Journal Article -
5
A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults
Published in Journal of Alzheimer's disease (01-01-2021)“…Rapid technological advances offer a possibility to develop cost-effective digital cognitive assessment tools. However, it is unclear whether these measures…”
Get more information
Journal Article -
6
Brief digital cognitive assessment for detection of cognitive impairment in low‐ and middle‐income countries
Published in Alzheimer's & dementia (01-12-2021)“…Background Rapid technological advances offer a possibility to develop cost‐effective digital cognitive assessment tools. However, it is unclear whether these…”
Get full text
Journal Article -
7
NeuroEPO plus (NeuralCIM ® ) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial
Published in Alzheimer's research & therapy (13-12-2023)“…NeuroEPO plus is a recombinant human erythropoietin without erythropoietic activity and shorter plasma half-life due to its low sialic acid content. NeuroEPO…”
Get full text
Journal Article